148 related articles for article (PubMed ID: 29928445)
1. Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells.
Wang X; Wu B; Zhong Z
Oncol Lett; 2018 Jul; 16(1):585-593. PubMed ID: 29928445
[TBL] [Abstract][Full Text] [Related]
2. C21 steroid-enriched fraction refined from
Zhang Y; Li K; Ying Y; Chen B; Hao K; Chen B; Zheng Y; Lyu J; Tong X; Chen X; Wang Y; Zhan Z; Zhang W; Wang Z
Oncotarget; 2017 Dec; 8(66):110576-110591. PubMed ID: 29299170
[No Abstract] [Full Text] [Related]
3. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
4. YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway.
Zhou Y; Wang Y; Zhou W; Chen T; Wu Q; Chutturghoon VK; Lin B; Geng L; Yang Z; Zhou L; Zheng S
Cancer Cell Int; 2019; 19():179. PubMed ID: 31337986
[TBL] [Abstract][Full Text] [Related]
5. Role of YAP in lung cancer resistance to cisplatin.
Song J; Xie LX; Zhang XY; Hu P; Long MF; Xiong F; Huang J; Ye XQ
Oncol Lett; 2018 Sep; 16(3):3949-3954. PubMed ID: 30128013
[TBL] [Abstract][Full Text] [Related]
6. Anti-neoplastic effect of mangiferin on human ovarian adenocarcinoma OVCAR8 cells via the regulation of YAP.
He W; You Y; Du S; Lei T; Wang H; Li X; He X; Tong R; Wang Y
Oncol Lett; 2019 Jan; 17(1):1008-1018. PubMed ID: 30655860
[TBL] [Abstract][Full Text] [Related]
7. Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma.
Liu F; Wang G; Wang X; Che Z; Dong W; Guo X; Wang Z; Chen P; Hou D; Zhang Q; Zhang W; Pan Y; Yang D; Liu H
Oncotarget; 2017 Apr; 8(17):27953-27965. PubMed ID: 28427193
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of Hpo signaling and YAP in hepatocellular carcinoma.
Valero V; Pawlik TM; Anders RA
J Hepatocell Carcinoma; 2015; 2():69-78. PubMed ID: 27508196
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
Lu T; Sun L; Zhu X
Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
[TBL] [Abstract][Full Text] [Related]
10. Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP.
Li M; Chen J; Yu X; Xu S; Li D; Zheng Q; Yin Y
Cells; 2019 Apr; 8(4):. PubMed ID: 30999669
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated FSTL5 inhibits invasion of hepatocellular carcinoma through the Wnt/β-catenin/YAP pathway.
Zhang DY; Sun WL; Ma X; Zhang P; Wu W; Wu H; Zhou S; Lu Z
Int J Clin Exp Pathol; 2017; 10(10):10325-10333. PubMed ID: 31966367
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Growth-Arrest-Specific Transcript 5 Improved Cisplatin Sensitivity in Hepatocellular Carcinoma Through Sponging miR-222.
Zhao P; Cui X; Zhao L; Liu L; Wang D
DNA Cell Biol; 2020 Apr; 39(4):724-732. PubMed ID: 32213078
[TBL] [Abstract][Full Text] [Related]
14. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
15. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
16. MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.
Yu S; Jing L; Yin XR; Wang MC; Chen YM; Guo Y; Nan KJ; Han LL
Oncotarget; 2017 Nov; 8(59):99757-99771. PubMed ID: 29245938
[TBL] [Abstract][Full Text] [Related]
17. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
18. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
[TBL] [Abstract][Full Text] [Related]
19. Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma.
Tao Y; Shan L; Xu X; Jiang H; Chen R; Qian Z; Yang Z; Liang B; Zheng H; Cai F; Yu Y; Ma L
J Cancer; 2018; 9(21):3962-3970. PubMed ID: 30410600
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
